SEARCH

SEARCH BY CITATION

References

  • Ayala G. X. and Tapia R. (2003) Expression of heat shock protein 70 induced by 4-aminopyridine through glutamate-mediated excitotoxic stress in rat hippocampus in vivo. Neuropharmacology 45, 649660.
  • Carriedo S. G., Yin H. Z., Lamberta R. and Weiss J. H. (1995) In vitro kainate injury to large, SMI-32(+) spinal neurons is Ca2+ dependent. Neuroreport 6, 945948.
  • Carriedo S. G., Yin H. Z. and Weiss J. H. (1996) Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 16, 40694079.
  • Cleveland D. W. and Rothstein J. D. (2002) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2, 806819.
  • Fragoso-Veloz J. and Tapia R. (1992) NMDA receptor antagonists protect against seizures and wet-dog shakes induced by 4-aminopyridine. Eur. J. Pharmacol. 221, 275280.
  • Hirata A., Nakamura R., Kwak S., Nagata N. and Kamakura K. (1997) AMPA receptor-mediated slow neuronal death in the rat spinal cord induced by long-term blockade of glutamate transporters with THA. Brain Res. 771, 3744.
  • Hugon J., Vallat J. M., Spencer P. S., Leboutet M. J. and Barthe D. (1989) Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord. Neurosci. Lett. 104, 258262.
  • Ikonomidou C., Qin Y. Q., Labruyere J. and Olney J. W. (1996) Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 55, 211224.
  • Julien J. P. (2001) Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 104, 581591.
  • Kwak S. and Nakamura R. (1995) Acute and late neurotoxicity in the rat spinal cord in vivo induced by glutamate receptor agonists. J. Neurol. Sci. 129 (Suppl.), 99103.
  • Liu S., Ruenes G. L. and Yezierski R. P. (1997) NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord. Brain Res. 756, 160167.
  • Massieu L. and Tapia R. (1997) Glutamate uptake impairment and neuronal damage in young and aged rats in vivo. J. Neurochem. 69, 11511160.
  • Massieu L., Morales-Villagrán A. and Tapia R. (1995) Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J. Neurochem. 64, 22622272.
  • Morales-Villagrán A. and Tapia R. (1996) Preferential stimulation of glutamate release by 4-aminopyridine in rat striatum in vivo. Neurochem. Int. 28, 3540.
  • Morales-Villagrán A., Ureña-Guerrero M. E. and Tapia R. (1996) Protection by NMDA receptor antagonists against seizures induced by intracerebral administration of 4-aminopyridine. Eur. J. Pharmacol. 305, 8793.
  • Nakamura R., Kamakura K. and Kwak S. (1994) Late-onset selective neuronal damage in the rat spinal cord induced by continuous intrathecal administration of AMPA. Brain Res. 654, 279285.
  • Peña F. and Tapia R. (1999) Relationships among seizures, extracellular amino acid changes, and neurodegeneration induced by 4-aminopyridine in rat hippocampus: a microdialysis and electroencephalographic study. J. Neurochem. 72, 20062014.
  • Peña F. and Tapia R. (2000) Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels. Neuroscience 101, 547561.
  • Petralia R. S., Rubio M. E., Wang Y. X. and Wenthold R. J. (2000) Regional and synaptic expression of ionotropic glutamate receptors. In: Handbook of Chemical Neuroanatomy, Vol. 18,Glutamate (Ottersen, O. P. and Storm-Mathisen, J., eds), pp. 145182. Elsevier Science, Amsterdam.
  • Plaitakis A. (1990) Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann. Neurol. 28, 38.
  • Rosen D. R., Siddique T., Patterson D. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 5962.
  • Rothstein J. D. and Kuncl R. W. (1995) Neuroprotective strategies in a model of chronic glutamate-mediated motor neurons toxicity. J. Neurochem. 65, 643651.
  • Rothstein J. D., Tsai G., Kuncl R. W., Clawson L., Cornblath D. R., Drachman D. B., Pestronk A., Stauch B. L. and Coyle J. T. (1990) Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28, 1825.
  • Rothstein J. D., Martin L. J. and Kuncl R. W. (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. New Engl. J. Med. 326, 14641468.
  • Rothstein J. D., Jin L., Dykes-Hoberg M. and Kuncl R. W. (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl Acad. Sci. USA 90, 65916595.
  • Rothstein J. D., Van Kammen M., Levey A. I., Martin L. J. and Kuncl R. W. (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 7384.
  • Salazar P., Montiel T., Brailowsky S. and Tapia R. (1994) Decrease of glutamate decarboxylase activity after in vivo cortical infusion of γ-aminobutyric acid. Neurochem. Int. 24, 363368.
  • Shaw P. J. (1999) Calcium, glutamate, and amyotrophic lateral sclerosis: more evidence but no certainties. Ann. Neurol. 46, 803805.
  • Shaw P. J., Forrest V., Ince P. G., Richardson J. P. and Wastell H. J. (1995) CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4, 209216.
  • Spreux-Varoquaux O., Bensimon G., Lacomblez L., Salachas F., Pradat P. F., Le Forestier N., Marouan A., Dib M. and Meininger V. (2002) Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J. Neurol. Sci. 193, 7378.
  • Sundström E., Mo L.-L. and Seiger A. (1995) In vivo studies on NMDA-evoked release of amino acids in the rat spinal cord. Neurochem. Int. 27, 185193.
  • Tapia R., Medina-Ceja L. and Peña F. (1999) On the relationship between extracellular glutamate, hyperexcitation and neurodegeneration, in vivo. Neurochem. Int. 34, 2331.
  • Urca G. and Urca R. (1990) Neurotoxic effects of excitatory amino acids in the mouse spinal cord: quisqualate and kainate but not N-methyl-D-aspartate induce permanent neural damage. Brain Res. 529, 715.
  • Van Den Bosch L., Vandenberghe W., Klaassen H., Van Houtte E. and Robberech W. (2000) Ca2+-permeable AMPA receptors and selective vulnerability of motor neurons. J. Neurol. Sci. 180, 2934.
  • Vandenberghe W., Robberech W. and Brorson J. R. (2000a) AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. J. Neurosci. 20, 123132.
  • Vandenberghe W., Ihle E. C., Patneau D. K., Robberech W. and Brorson J. R. (2000b) AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability. J. Neurosci. 20, 71587166.
  • Velasco I., Tapia R. and Massieu L. (1996) Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures. J. Neurosci. Res. 44, 551561.
  • Williams T. L., Day N. C., Ince P. G., Kamboj R. K. and Shaw P. J. (1997) Calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 42, 200207.
  • Wisden W., Seeburg P. H. and Monyer H. (2000) AMPA, kainate and NMDA ionotropic glutamate receptor expression – an in situ hybridization atlas, in Handbook of Chemical Neuroanatomy, Vol. 18,Glutamate (Ottersen, O. P. and Storm-Mathisen, J., eds), pp. 99143. Elsevier Science, Amsterdam.
  • Young A. M. J. and Bradford H. F. (1991) N-Methyl-d-aspartate releases excitatory amino acids in rat corpus striatum in vivo. J. Neurochem. 56, 16771683.
  • Young A. M. J., Crowder J. M. and Bradford H. F. (1988) Potentiation by kainate of excitatory amino acid release in striatum: complementary in vivo and in vitro experiments. J. Neurochem. 50, 337345.